Dynamed | KZN Future 50
Updated | By KZN Future 50
Dynamed: Pioneering Medical Device Manufacturing in South Africa.
Dynamed, founded by Vinesh Maharaj and led by Ishan Maharaj, is a leading manufacturer of medical devices in South Africa. One of their notable products includes wound care dressings, catering to the healthcare sector's critical needs. The company's journey is a story of perseverance, learning from mistakes, and leveraging family business dynamics to drive long-term growth.
Coming from a background in shipping, Vinesh Maharajhad had a passion for healthcare but very little industry experience. Despite this, he saw an opportunity in this industry, and began importing medical consumables. Through a process of trial and error, he transformed the venture into Africa's foremost wound care dressing manufacturer. His son, Ishan Maharaj, an industrial engineering graduate, joined the company a decade ago, injecting fresh energy and innovation into its operations.
Read More: Livecopper | KZN Future 50
The success of Dynamed can be attributed to several factors. Firstly, its status as a family business ensures a focus on long-term goals and investments. Such businesses, transitioning from one generation to the next, become pillars of economic prosperity. Dynamed's commitment is evident in its substantial investments in manufacturing infrastructure, machinery, and quality assurance processes.
The company's significance extends beyond domestic borders. It supplies government hospitals and private healthcare institutions like Life Healthcare, fostering a reputation for reliability and quality. Securing accreditation from regulatory bodies like the Food and Drug Administration (FDA) in the United States is pivotal for Dynamed's expansion plans. This accreditation not only unlocks access to lucrative markets like the Middle East but also enhances credibility and trust among potential clients.
Read More: The Artisan Baker | KZN Future 50
The call to the KZN Community is to support Dynamed in crossing this FDA accreditation finish line. As any organisation who has walked this road will tell you, getting this accreditation comes with significant financial and procedural challenges. At this critical stage of this process, Dynamed finds itself in need of additional support to complete the process. Here, partnerships with larger corporate entities – such as Netcare – could present opportunities for mutual benefit.
Having this kind of support – both financially and strategically – would ensure Dynamed is able to complete this process. They believe that with an agreement in place with an organisation such as Netcare, confidence in the organisations prospects would be deepened, which would support their drive for additional funding. A partnership such as this one, would strengthen Dynamed's position in the local market but also opens avenues for international expansion and export opportunities, contributing to South Africa's economic growth and competitiveness.
Read More: EB Castings| KZN Future 50
Dynamed exemplifies the transformative potential of entrepreneurial spirit, resilience, and strategic partnerships in driving innovation and growth within the healthcare industry. As the company navigates its path towards FDA accreditation and beyond, its story serves as tangible example of South African businesses aspiring to make a global impact.
More from ECR
HOW TO LISTEN TO EAST COAST RADIO
- Listen to East Coast Radio on the FM (frequency modulation) spectrum between 94 and 95 FM on your radio.
- Listen live to ECR by clicking here or download the ECR App (iOS/Android).
- Listen to East Coast Radio on the DStv audio bouquet
- Switch to the audio bouquet on your Openview decoder and browse to channel 606
- Listen to us on Amazon Alexa.
Follow us on social media:
Image Supplied
Show's Stories
-
Happy World Hello Day! The many ways we say 'hello' in KZN
We agree that Adele and Lionel Richie did it well, but 'Hello' just does...
Danny Guselli 6 hours ago -
Yaz Plus: Here’s why the contraceptive was recalled
Bayer recalled Yaz Plus pills over a mix-up risking efficacy. Patients c...
Stacey & J Sbu 7 hours ago